-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRUM PHARMACEUTICALS AND INCYTE ANNOUNCE U.S. FDA APPROVAL OF ATEBRIOZ™ (ZILURGISERTIB) FOR ADULT AND PEDIATRIC PATIENTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Reuters·09/25/2026 23:00:00

Please log in to view news